arrow
K

Kevin Chan

city of hope comprehensive cancer center
H指数:22
被引数:2,508

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis

局部前列腺癌行根治性前列腺切除术的拉丁裔亚人群结局差异:一项基于人群的分析

Cancers
IF4.4
2026-04-030
OAAI
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer

肌层浸润性膀胱癌患者根治性膀胱切除术中病理疾病升级的临床预测因素及预后意义

2025-10-090
OA
Evaluation of Long-Term Outcomes Utilizing Indocyanine Green to Decrease Ureteroenteric Anastomotic Stricture During Robotic Radical Cystectomy and Extracorporeal Urinary Diversion

利用吲哚菁绿减少机器人根治性膀胱切除术及体外尿流改道术中输尿肠吻合口狭窄的长期疗效评估

2025-09-190
OAAI
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical Cystectomy

临床和病理学预测因子:在接受根治性膀胱切除术的临床淋巴结阴性的膀胱癌患者中 occult 淋巴结受累的预测因子

2025-09-010
PRE
Bladder Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
2024-05-0113
OA
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial (vol 29, pg 2825, 2023)
2024-01-191
OAAI
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
2023-10-0233
OAAI
Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines

膀胱癌,2.2022版更新了NCCN指南

2022-08-01171
OA
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study

在接受围手术期化疗的肌肉浸润性膀胱癌患者中,机器人辅助与开放根治性膀胱切除术: 来自多中心研究的肿瘤学家的观点

2018-12-016
OAAI